Skip to main content

Eduard Rodenas Alesina

Institutions of which they are part

Predoctoral researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Eduard Rodenas Alesina

Institutions of which they are part

Predoctoral researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Projects

Fisiología cardiovascular durante el ejercicio en pacientes adultos con circulación cavopulmonar de Fontan y análisis de la vasculopatía pulmonar mediante ultrasonografía intravascular (IVUS). Estudio EFI.

IP: Yassin Belahnech Pujol
Collaborators: Antonia Pijuan Domenech, Enric Domingo Ribas, Victor Gonzalez Fernandez, Eduard Rodenas Alesina, Gerard Marti Aguasca, Bruno García del Blanco, Berta Miranda Barrio, Laura Dos Subirá
Funding agency: -Sociedad Española de Cardiologia
Funding: 15000
Reference: SEC/BELAHNECH/2024
Duration: 01/10/2024 - 01/10/2025

Mechanisms of metabolic adaptation after weight loss in obesity. Clinical phenotyping and therapeutic approach.

IP: Andreea Ciudin Mihai
Collaborators: Cristina Gamez Cenzano, Eduard Rodenas Alesina, Ana Marti Delgado, Fiorella Ximena Palmas Candia, Bruno García del Blanco, Ana Belén Méndez Fernández, Ana Maria Ciscar Bellés, Aleix Olivella San emeterio, Marta Comas Martínez, Alvaro Calabuig Goena, Enzamaría Fidilio Meli, Marco Tomasino
Funding agency: Instituto de Salud Carlos III
Funding: 165000
Reference: PI23/01209
Duration: 01/01/2024 - 31/12/2026

AI4HF: Trustworthy Artificial Intelligence for Personalised Risk Assessment in Chronic Heart Failure

IP: Jose Fernando Rodríguez Palomares
Collaborators: Eduard Rodenas Alesina, Andrea Guala, Lydia Dux-Santoy Hurtado, Ignacio Ferreira González, Gisela Teixido Tura, Aroa Ruiz Muñoz
Funding agency: EUROPEAN COMMISSION
Funding: 293125
Reference: AI4HF_HE-HLTH-STAYHLTH2022
Duration: 01/06/2023 - 31/05/2027

Related news

The study, led by Vall d'Hebron, is the first in Spain to analyse the relationship between pregnancy complications and the risk of long-term cardiovascular diseases.

The consensus document is the result of multidisciplinary work that takes into account the risks associated with all stages of women's lives and the differences compared to men.

The study, which involved Vall d'Hebron, developed an action plan to efficiently allocate resources to patients most at risk of suffering this complication.

Related professionals

Sahyly Siurana Montilva

Sahyly Siurana Montilva

Neuroradiology
Read more
Lena Nerea Montaña Ernst

Lena Nerea Montaña Ernst

Research technician
Pharmacokinetic Nanoparticles
Read more
Lluisa Montesinos Magraner

Lluisa Montesinos Magraner

Head of group
Research Group of Physical Medicine and Rehabilitation
Read more
Carmen Llorens Cebriá

Carmen Llorens Cebriá

Tècnic/a Superior Recerca
High Technology Unit (UAT)
Preclinical Core Facilities
External Strategy Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.